Application 205055
- Type
- ANDA
- Sponsor
- ALVOGEN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NATEGLINIDE | NATEGLINIDE | TABLET;ORAL | 60MG | No | No |
| 002 | NATEGLINIDE | NATEGLINIDE | TABLET;ORAL | 120MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A205055-001 | NATEGLINIDE | NATEGLINIDE | 60MG | TABLET / ORAL | 2015-12-11 | ||
| A205055-002 | NATEGLINIDE | NATEGLINIDE | 120MG | TABLET / ORAL | 2015-12-11 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A205055-001 | NATEGLINIDE | 60MG | TABLET / ORAL | 2015-12-11 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A205055-002 | NATEGLINIDE | 120MG | TABLET / ORAL | 2015-12-11 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205055-001 | NATEGLINIDE | 60MG | TABLET / ORAL | 2015-12-11 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205055-002 | NATEGLINIDE | 120MG | TABLET / ORAL | 2015-12-11 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A205055-001 | NATEGLINIDE | 60MG | TABLET / ORAL | 2015-12-11 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A205055-002 | NATEGLINIDE | 120MG | TABLET / ORAL | 2015-12-11 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205055-001 | NATEGLINIDE | 60MG | TABLET / ORAL | 2015-12-11 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205055-002 | NATEGLINIDE | 120MG | TABLET / ORAL | 2015-12-11 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205055-001 | NATEGLINIDE | 60MG | TABLET / ORAL | 2015-12-11 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205055-002 | NATEGLINIDE | 120MG | TABLET / ORAL | 2015-12-11 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205055-001 | NATEGLINIDE | 60MG | TABLET / ORAL | 2015-12-11 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205055-002 | NATEGLINIDE | 120MG | TABLET / ORAL | 2015-12-11 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A205055-001 | NATEGLINIDE | 60MG | TABLET / ORAL | 2015-12-11 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A205055-002 | NATEGLINIDE | 120MG | TABLET / ORAL | 2015-12-11 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A205055-001 | NATEGLINIDE | 60MG | TABLET / ORAL | 2015-12-11 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A205055-002 | NATEGLINIDE | 120MG | TABLET / ORAL | 2015-12-11 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A205055-001 | NATEGLINIDE | 60MG | TABLET / ORAL | 2015-12-11 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A205055-002 | NATEGLINIDE | 120MG | TABLET / ORAL | 2015-12-11 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A205055-001 | NATEGLINIDE | 60MG | TABLET / ORAL | 2015-12-11 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A205055-002 | NATEGLINIDE | 120MG | TABLET / ORAL | 2015-12-11 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A205055-001 | NATEGLINIDE | 60MG | TABLET / ORAL | 2015-12-11 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A205055-002 | NATEGLINIDE | 120MG | TABLET / ORAL | 2015-12-11 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A205055-001 | NATEGLINIDE | 60MG | TABLET / ORAL | 2015-12-11 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A205055-002 | NATEGLINIDE | 120MG | TABLET / ORAL | 2015-12-11 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A205055-001 | NATEGLINIDE | 60MG | TABLET / ORAL | 2015-12-11 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A205055-002 | NATEGLINIDE | 120MG | TABLET / ORAL | 2015-12-11 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A205055-001 | NATEGLINIDE | 60MG | TABLET / ORAL | 2015-12-11 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A205055-002 | NATEGLINIDE | 120MG | TABLET / ORAL | 2015-12-11 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A205055-001 | NATEGLINIDE | 60MG | TABLET / ORAL | 2015-12-11 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A205055-002 | NATEGLINIDE | 120MG | TABLET / ORAL | 2015-12-11 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A205055-001 | NATEGLINIDE | 60MG | TABLET / ORAL | 2015-12-11 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A205055-002 | NATEGLINIDE | 120MG | TABLET / ORAL | 2015-12-11 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A205055-001 | NATEGLINIDE | 60MG | TABLET / ORAL | 2015-12-11 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A205055-002 | NATEGLINIDE | 120MG | TABLET / ORAL | 2015-12-11 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A205055-001 | NATEGLINIDE | 60MG | TABLET / ORAL | AB | 2015-12-11 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A205055-002 | NATEGLINIDE | 120MG | TABLET / ORAL | AB | 2015-12-11 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A205055-001 | NATEGLINIDE | 60MG | TABLET / ORAL | 2015-12-11 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A205055-002 | NATEGLINIDE | 120MG | TABLET / ORAL | 2015-12-11 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A205055-001 | NATEGLINIDE | 60MG | TABLET / ORAL | 2015-12-11 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A205055-002 | NATEGLINIDE | 120MG | TABLET / ORAL | 2015-12-11 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A205055-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A205055-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A205055-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A205055-002 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A205055-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A205055-002 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A205055-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A205055-002 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nateglinide | NATEGLINIDE | Golden State Medical Supply, Inc. | e920b343-f53e-7487-e053-2995a90a719a | 2025-04-15 | Warnings, Adverse reactions | Nateglinide NATEGLINIDE |
| Nateglinide | NATEGLINIDE | Strides Pharma Science Limited | 0ccf9b07-3c21-482d-abeb-a06ceb482c7b | 2025-02-24 | Warnings, Adverse reactions | Nateglinide NATEGLINIDE |
| Nateglinide | NATEGLINIDE | American Health Packaging | b17ead66-dc11-4e54-9ba6-00619510f27b | 2025-01-07 | Warnings, Adverse reactions | Nateglinide NATEGLINIDE |
| Nateglinide | NATEGLINIDE | Zydus Lifesciences Limited | a82817dd-f8c4-4172-ba86-63c2beef456a | 2024-12-03 | Nateglinide NATEGLINIDE | |
| NATEGLINIDE | NATEGLINIDE | Rising Pharma Holdings, Inc. | b41f4180-96a7-411d-b827-5021e534f556 | 2024-12-03 | Warnings, Adverse reactions | NATEGLINIDE NATEGLINIDE |
| Nateglinide | NATEGLINIDE | Zydus Pharmaceuticals USA Inc. | 88698921-cd8f-4d41-96e6-ff671913c5c3 | 2023-11-07 | Warnings, Adverse reactions | Nateglinide NATEGLINIDE |
| Nateglinide | NATEGLINIDE | Cadila Pharmaceuticals Limited | c678b772-acba-4b59-a0b2-d70d84283425 | 2022-12-28 | Warnings, Adverse reactions | Nateglinide NATEGLINIDE |
| Nateglinide | NATEGLINIDE | Dr. Reddy's Laboratories Limited | f7b28951-76d2-cabd-64a1-b74aa225c6e9 | 2021-11-27 | Warnings, Adverse reactions | Nateglinide NATEGLINIDE |
| Nateglinide | NATEGLINIDE | Modavar Pharmaceuticals LLC | af81465b-5f49-4eeb-8122-ef7fe5d90ddc | 2021-08-03 | Warnings, Adverse reactions | Nateglinide NATEGLINIDE |
| NATEGLINIDE | NATEGLINIDE | Nivagen Pharmaceuticals, Inc. | 21b211b5-cc92-490f-9903-42fff6a946cd | 2021-01-15 | Warnings, Adverse reactions | NATEGLINIDE NATEGLINIDE |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 32623 | ORIG | 2015-12-16 |